ClinicalTrials.gg
CompletedNCT03748121YOGAPTSDUpdated Dec 6, 2022

Yoga/Pranayama for Posttraumatic Stress Disorder

An interventional study of Pranayama assisted trauma-focused Cognitive Behavioral Therapy (TF-CBT) and Trauma-focused Cognitive Behavioral Therapy (TF-CBT) in Posttraumatic Stress Disorder, sponsored by Universität Duisburg-Essen. Completed at 1 site in Germany. Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2022-12-06.

Sponsored by Universität Duisburg-Essen · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 8 months after the study started (first participant enrolled Feb 2018, registered Nov 2018).
Phase
Not applicable
Study type
Interventional
Enrollment
74
Allocation
Randomized
Ages
18 Years to 70 Years
Sex
All
01

Study summary

This study aims to investigate the effect of a pranayama focused yoga intervention on post-traumatic symptom severity in patients with post-traumatic stress disorder undergoing standard psychotherapy/ trauma-focused cognitive-behavioral therapy (TF-CBT). Therefore, short pranayama sessions of 5-10 minutes will be provided to the patients directly at the begin of each of standard TF-CBT unit, while the control group will get standard TF-CBT alone. It should further be investigated, whether pranayama can enhance the affective tolerance of patients with post-traumatic stress disorder towards the used exposure techniques of TF-CBT.

02

Conditions studied

  • Posttraumatic Stress Disorder

Keywords

  • Posttraumatic Stress Disorder
  • Cognitive-Behavioral Therapy
  • Complementary Therapies
  • Yoga
  • Pranayama
  • Effectiveness
  • Safety
  • Randomized Controlled Trial
03

In context

Stress Disorders, Post-Traumatic

2,284 studies on the registry are indexed under Stress Disorders, Post-Traumatic; 557 are open to participants now.

This study's enrollment of 74 is close to the median of 70 across 1,897 interventional studies indexed under Stress Disorders, Post-Traumatic.

Browse Stress Disorders, Post-Traumatic studies →

Lead sponsor

Universität Duisburg-Essen is the lead sponsor of 85 studies on the registry; 14 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Diagnosed PTSD according to ICD-10
  • PCL-5 Score of at least 33 points
  • Undergoing outpatient CBT
  • Physical and mental ability to perform Pranayama

Exclusion criteria

Exclusion Criteria:

  • Severe comorbid mental or somatic disease that did not allow the patient to perform Pranayama
  • Pregnancy
  • Regular practice of Yoga or Pilates in the last 12 months
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
74 participants (actual)

Study arms

  • Experimental
    Pranayama assisted Trauma-focused Cognitive Behavioral Therapy (TF-CBT)

    To prepare patients for the TF-CBT, they received 5-10 minutes of pranayama at the begin of each of the 10 TF-CBT units.

    Behavioral: Pranayama assisted trauma-focused Cognitive Behavioral Therapy (TF-CBT)

  • Active comparator
    Trauma-focused Cognitive Behavioral Therapy (TF-CBT)

    Patients wait for 10 TF-CBT units and then are offered to learn pranayama.

    Behavioral: Trauma-focused Cognitive Behavioral Therapy (TF-CBT)

Interventions

  • BehavioralPranayama assisted trauma-focused Cognitive Behavioral Therapy (TF-CBT)

    The pranayama intervention is placed directly at the begin of the respective TF-CBT unit and will be repeated for 10 subsequent TF-CBT units. Pranayama contains the performance of Kapalabhati, Ujjayi, and/or Nadi Shodhana (for overall 1 minute) as well as following Kumbhaka (intentional respiratory reflex inhibition). Pranayama will be repeated 3 times before each TF-CBT unit.

  • BehavioralTrauma-focused Cognitive Behavioral Therapy (TF-CBT)

    Trauma-focused Cognitive Behavioral Therapy (TF-CBT)

06

What researchers measure

Primary outcomes

  1. Intensity of posttraumtic symptoms

    Posttraumatic Stress Disorder Checklist for DSM-5 (PCL-5): The PCL-5 is a standard 20-item scale with a sum score ranging from 0 to 80 points. The cut-off point for clinically relevant symptom severity is 33 points.

    Time frame: week 10

Secondary outcomes

  1. Health-related quality of life

    Short Form 12 Health Survey (SF-12): The SF-12 is a standard 12-item scale with two sum scores (physical and mental quality of life) ranging from 0 to 100 points.

    Time frame: week 10

  2. Ability of social participation

    Patient-Reported Outcomes Measurement Information System - Ability to Participate in Social Roles and Activities Scale (PROMIS): The PROMIS-Social Participation Subscale is a standard 8-item scale ranging from 0 to 100 points with 100 points represent the highest possible ability to participate/function.

    Time frame: week 10

  3. Anxiety

    Beck Anxiety Inventory (BAI): The BAI is a standard 21-items scale ranging from 0 to 63 points with 0-7 points = minimal anxiety, 8-15 points = mild anxiety, 16-25 points = moderate anxiety, and 26-63 points = clinically relevant anxiety.

    Time frame: week 10

  4. Depression

    Beck Depression Inventory Revision (BDI-II): The BDI-II is a standard 21-items scale ranging from 0 to 63 points with 0-13 points =no/clinically not relevant depression/depression in remission, 14-19 points = mild depression, 20-28 points = moderate depression und 29-63 points = severe depression.

    Time frame: week 10

  5. Distress Tolerance

    Distress Tolerance Scale (DTS): The DTS is a standard 15-item scale ranging from 0 to 75 points. Higher scores represent higher distress tolerance.

    Time frame: week 10

  6. Emotion Regulation

    Emotion Regulation Scale (ERQ): The ERQ is a standard 10-item scale with 6 items are added to the Cognitive Reappraisal subscale ranging from 6 to 42 and 4 items are added to the Expressive Suppression subscale ranging from 4 to 28. Higher scores on the Cognitive Reappraisal subscale and lower ones on the Expressive Suppression subscale represent a better regulation of emotions.

    Time frame: week 10

  7. Body Awareness

    Scale of Body Connection (SBC): The SBC is a standard 20-items scale ranging from 0 to 80 that contains two subscales: Body Awareness and Body Dissociation. Higher scores on Body Awareness and lower scores on Body Dissociation represent a better body awareness.

    Time frame: week 10

  8. Breath Holding Duration

    Breath Holding Task (BHT): The BHT is standard test procedure for the measurement of ability of the suppression of the respiratory reflex. In PTSD patients, it is associated with distress tolerance.

    Time frame: week 10

  9. Acute Emotional Stress

    Emotional Stress Reaction Questionnaire (ESRQ): The ESRQ is standard 14-items scale ranging from -21 points (predominance of negative emotions) to +21 points (predominance of positive emotions). Patients received the ESRQ before and after each CBT unit.

    Time frame: week 1, 2, 3, 4, 5, 6, 7, 8, 9, 10

  10. Adverse Events

    Number of patients with adverse events (and type of the adverse event)

    Time frame: week 1, 2, 3, 4, 5, 6, 7, 8, 9, 10

Other outcomes

  1. Treatment Expectation

    Treatment Credibility Scale (TCS): The TCS is a standard NRS scale ranging from 0 points (lowest expectation of treatment effectiveness) to 10 points (highest expectation of treatment effectiveness).

    Time frame: week 0

07

Study locations

1 site
  • Dietmar Mitzinger
    Neuss, North Rhine-Westphalia 41460, Germany
08

References and documents

Publications

  • Haller H, Mitzinger D, Cramer H. The integration of yoga breathing techniques in cognitive behavioral therapy for post-traumatic stress disorder: A pragmatic randomized controlled trial. Front Psychiatry. 2023 Apr 17;14:1101046. doi: 10.3389/fpsyt.2023.1101046. eCollection 2023. PubMed 37139325 ↗

Individual participant data

Plan to share: Undecided — Upon reasonable request.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Feb 2018 to primary completion in Jul 2020, 29 months.

Of 911 non-industry interventional studies with no phase under Stress Disorders, Post-Traumatic, half reached primary completion within 35 months of starting (the median), counting those still running; a quarter within 17 and three quarters within 53. This study's 29 months is below that.

Counting every sponsor, half of 937 studies reached it within 35 months; a quarter within 17 and three quarters within 53.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 16, 2018
First posted
Nov 20, 2018
StartActual
Feb 20, 2018
Primary completionActual
Jul 31, 2020
CompletionActual
Jul 31, 2020
Last update
Dec 6, 2022
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 6, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03748121
Lead sponsor
Universität Duisburg-Essen
Responsible party
Heidemarie Haller (Postdoctoral Research Fellow, Universität Duisburg-Essen) — Principal investigator
First posted
Nov 20, 2018
Start date
Feb 20, 2018
Primary completion
Jul 31, 2020
Completion
Jul 31, 2020
Last update
Dec 6, 2022

Study contacts

Gustav Dobos, Prof. MD
study director · University of Duisburg-Essen

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion